Pharma News
-
Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline
Pharma | News | 0 Comment | 22 Mar, 2019
Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/dementia pipeline, including anti-amyloid beta (Abeta) protofibril anti...Read more
-
Hyphens Pharma inks MoU with A*STAR for Derma research
Pharma | News | 0 Comment | 22 Mar, 2019
Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR’s Institute of Chemical and Engineering Sciences (ICES). By leveraging A*STAR’s res...Read more
-
Vertex receives approval for CF drug in Australia
Pharma | News | 0 Comment | 20 Mar, 2019
Vertex Pharmaceuticals Incorporated has announced that the Therapeutic Goods Administration (TGA) of Australia has granted registration to SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) ...Read more
-
Blackstone to acquire AYUMI Pharmaceutical
Pharma | News | 0 Comment | 18 Mar, 2019
Blackstone has announced that private equity funds managed by Blackstone have entered into a definitive agreement to acquire AYUMI Pharmaceutical Corporation, pharmaceutical company in Japa...Read more
-
Pharmaceutics International gets EIR from FDA
Pharma | News | 0 Comment | 18 Mar, 2019
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) has announced that the U.S. Food and Drug Administration (FDA) has issued their Establi...Read more
-
Théa, OliX to develop RNAi therapies for AMD treatment
Pharma | News | 0 Comment | 18 Mar, 2019
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced that it has signed a license and collaboration agreement with Théa Open Innovation, part of the La...Read more
-
Chugai’s Hemlibra receives approval for severe Hemophilia A
Pharma | News | 0 Comment | 15 Mar, 2019
Chugai Pharmaceutical has announced that Roche received the decision from the European Commission confirming that Hemlibra® (emicizumab), a hemophilia A treatment originated by Chu...Read more
-
Aprecia, CMIC to bring 3DP pharmaceutical products to Japan
Pharma | News | 0 Comment | 15 Mar, 2019
Privately held Aprecia Pharmaceuticals, LLC (Aprecia) and CMIC CMO Co., LTD (CMIC CMO) have announced that both companies will collaborate to develop business opportunities in Jap...Read more
-
Glenmark receives ANDA approval for Clindamycin and Benzoyl Peroxide Gel, 1%|5%
Pharma | News | 0 Comment | 15 Mar, 2019
Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin and Benzoyl Peroxide Gel, 1%|5%, a generic versi...Read more
-
Zydus set to market generic anti-diabetic drug
Pharma | News | 0 Comment | 15 Mar, 2019
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies The company has received the tentative...Read more
-
Ajinomoto Bio-Pharma services announces its assets expansion
Pharma | News | 0 Comment | 13 Mar, 2019
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global company which is fully integrated contract development and manufacturing organization with sites in Belgium, Uni...Read more
-
CStone receives IND approval in China for HDAC6 inhibitor CS3003
Pharma | News | 0 Comment | 13 Mar, 2019
CStone Pharmaceuticals announced that the National Medical Products Administration (NMPA) recently approved company's histone deacetylase 6 (HDAC6) selective inhibitor CS3003 for Phase I cl...Read more
-
FDA approves Regeneron, Sanofi's Dupixent to treat atopic dermatitis
Pharma | News | 0 Comment | 12 Mar, 2019
Regeneron Pharmaceuticals and Sanofi have announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for adolescent patients 12 to...Read more
-
Oncoceutics licenses rights for its anti-cancer compound to Ohara
Pharma | News | 0 Comment | 12 Mar, 2019
US based Oncoceutics, Inc. has announced the outlicense of the rights to the company’s lead compound, ONC201, for Japan to Ohara Pharmaceutical Co., Ltd. In addition, Ohara will recei...Read more
-
ASLAN signs news commercialisation agreement with BioGenetics
Pharma | News | 0 Comment | 11 Mar, 2019
ASLAN Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, and BioGenetics Co Ltd, a leading South Korean healthcar...Read more
-
TaiwanJ Pharma signs $26M deal with Newsoara Biopharma
Pharma | News | 0 Comment | 11 Mar, 2019
TaiwanJ Pharmaceuticals has signed a $26 million contract with Newsoara Biopharma to license out its drug candidate JKB-122 for further development in Asia. On March 2nd, 2019, TaiwanJ ann...Read more
-
West opens new digital technology centre in India
Pharma | News | 0 Comment | 08 Mar, 2019
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has officially opened the Company’s new Digital Technology centre (DTC)...Read more
-
Pharma | News | 0 Comment | 07 Mar, 2019
Pacira Pharmaceuticals, Inc. and MyoScience, Inc. a privately held medical technology company, have announced the signing of a definitive agreement for the acquisition of MyoScience by...Read more
